企業プロフィール
MiMedx 株価・ニュース・カタリスト
- ティッカー:
- MDXG
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
4.19 USD (-1.87%)
終値
最終更新: 2026年8月17日
532M USD
時価総額
株価変動の要因
As of Aug 17, 2026, MDXG closed down 1.87% at $4.19. No new same-company headline was identified in the current news window.
企業概要
Placental Tissue Products
MIMEDX develops and commercializes placental-tissue products for wound care, burns and surgery. Its processing and product portfolio are designed to provide extracellular-matrix and biologic materials that support healing and tissue repair.
Wound-Care Portfolio
The company has more than a decade of experience serving chronic and difficult-to-heal wounds. Products are used by clinicians across outpatient and other care settings where advanced wound coverage and healing support are required.
Surgical and Pipeline Products
The surgical portfolio includes AMNIOFIX, AMNIOEFFECT and particulate products. MIMEDX is also investing in newer products such as CHORIOFIX and in a randomized controlled study of EPIEFFECT.
今後のカタリスト
- MiMedx's catalysts are wound-care growth and placental-biologic demand, with the stock moving on commercial execution rather than headline science. The company improves when the commercial base keeps compounding.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。